CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

Culinary Health Fund

Culinary Health Fund is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zwanger Pesiri Radiology Group

Zwanger Pesiri Radiology Group is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lindenhurst, NY. To find more information about Zwanger Pesiri Radiology Group, please visit www.zwangerpesiri.com

Cgmp Validations

Cgmp Validations is a Mission, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beverly Hospital

Beverly Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Montebello, CA. To find more information about Beverly Hospital, please visit www.beverly.org

Spectranetics

Spectranetics is dedicated to managing every lead and eradicating restenosis and amputation. We do this by helping physicians, patients, and hospitals maximize cardiovascular health. Our company is committed to inventing, selling, and supporting technology that enables success during the most challenging minimally invasive cardiovascular procedures. We provide expert physician training, including the only lead removal simulator in the industry, as well as extensive patient and physician education.    The Company’s Lead Management (LM) division is dedicated to helping physicians safely manage every lead. We provide the expert tools, training and ongoing support – including the only available lead extraction simulator – that allow physicians precision, control and versatility while extracting leads, so they can focus more on the patient’s overall status while generating positive outcomes.    The Vascular Intervention (VI) division is dedicated to helping physicians address the challenges of peripheral and coronary artery disease. We provide expert tools, training, ongoing support, and patient education so that you can help eradicate restenosis and amputation